Subjective cognitive decline (SCD) is a potential early marker of neurodegeneration, with negative affective states such as depression and anxiety significantly contributing to cognitive impairment. Digital treatments show promise, yet evidence of their use…
Continue Reading
Tombot, a California-based robotics company that makes a robotic puppy that serves as a companion animal for people who cannot care for a live animal, announced that it has closed an oversubscribed $6.1 million…
Continue Reading
What You Should Know:
– Neurogen Biomarking announced a strategic partnership with NeuroX, a venture of American TelePhysicians, to integrate virtual neurology services into Neurogen’s innovative brain health care ecosystem. The collaboration aims to…
Continue Reading
Background: Frail older adults are at greater risk of adverse health-related outcomes such as falls, disability, and mortality. Mild behavioral impairment (MBI), which is characterized by neurobehavioral symptoms in individuals without dementia, is a…
Continue Reading
What You Should Know:
– Linus Health has introduced Anywhere for Health Systems™, an innovative, FDA-listed, AI-enhanced cognitive assessment designed to address the critical issue of undetected mild cognitive impairment (MCI), a precursor to dementia.
–…
Continue Reading
This systematic review evaluated natural language processing (NLP) approaches for detecting cognitive impairment in electronic health record clinical notes. Following PRISMA guidelines, we analyzed 18 studies (n = 1,064,530) that employed rule-based algorithms (67%), traditional machine…
Continue Reading
A new AI-based tool that gamifies the screening of mild cognitive impairment has been incorporated into a comprehensive health screening service in Singapore.ReCOGnAIze is a neuroscientific game application developed at the Lee Kong Chian School…
Continue Reading
A new report by Milliman, Inc. concluded that after testing the impact of various modifications to Together Senior Health’s Dementia AlgoRithm, new claims-sourced models demonstrate positive predictive value that can support quality care.WHY IT…
Continue Reading
Cognitive impairment, marked by neurodegenerative damage, leads to diminished cognitive function decline. Accurate cognitive assessment is crucial for early detection and progress evaluation, yet current methods in clinical practice lack objectivity, precision, and convenience….
Continue Reading
Linus Health, a digital health company focused on early detection of Alzheimer’s and other dementias, announced that its Core Cognitive Evaluation (CCE) platform has obtained European Union (EU) Medical Device Regulation (MDR) Class IIa…
Continue Reading
